FAKTOR-OPTIONSSCHEIN - BALCHEM CO. Stock

Certificat

DE000MC8G7P4

Delayed Börse Stuttgart 04:26:56 2024-06-14 EDT
0.104 EUR -1.89% Intraday chart for FAKTOR-OPTIONSSCHEIN - BALCHEM CO.
Current month-9.40%
1 month-21.48%
Date Price Change
24-06-14 0.104 -1.89%
24-06-13 0.106 -8.62%
24-06-12 0.116 +14.85%
24-06-11 0.101 -3.81%
24-06-10 0.105 -6.25%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 04:26 am

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying BALCHEM CORPORATION
Issuer Morgan Stanley
WKN MC8G7P
ISINDE000MC8G7P4
Date issued 2020-04-08
Strike 130.6 $
Maturity Unlimited
Parity 182.43 : 1
Emission price 10
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 22.46
Lowest since issue 0.035

Company Profile

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Sector
-
More about the company

Ratings for Balchem Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Balchem Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
152.3 USD
Average target price
166 USD
Spread / Average Target
+8.99%
Consensus